Institutional Ownership Novo Cure LTD (NVCR)
This table provides information about the institutional ownership of Novo Cure LTD (NVCR). We have compiled data on the 262 institutions that hold shares in the stock, with a total of 77 Million shares, which have been reported (via 13F filing form) to have a value of $1.32 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
12,132,397
shares
|
$215 Million
0.0% of portfolio
|
Q2 2024
Added 33.55%
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
11,844,608
shares
|
$210 Million
0.0% of portfolio
|
Q3 2024
Added 6.45%
|
|
Capital International Investors
Los Angeles, CA |
Nov 13, 2024 Q3 2024 |
7,922,761
shares
|
$140 Million
0.02% of portfolio
|
Q3 2024
Reduced 32.26%
|
|
Capital World Investors
Los Angeles, CA |
Nov 13, 2024 Q3 2024 |
4,308,218
shares
|
$76.4 Million
0.01% of portfolio
|
Q3 2024
Added 86.65%
|
|
Nordwand Advisors, LLC
Radnor, PA |
Nov 01, 2024 Q3 2024 |
3,029,824
shares
|
$53.7 Million
12.67% of portfolio
|
Q3 2024
Added 99.99%
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
2,806,133
shares
|
$49.8 Million
0.03% of portfolio
|
Q3 2024
Added 63.87%
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
2,729,988
shares
|
$48.4 Million
0.0% of portfolio
|
Q3 2024
Reduced 9.17%
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
2,405,257
shares
|
$42.6 Million
0.0% of portfolio
|
Q3 2024
Added 1.26%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
2,322,196
shares
|
$41.2 Million
0.0% of portfolio
|
Q3 2024
Added 7.71%
|
|
Baillie Gifford & CO
|
Nov 05, 2024 Q3 2024 |
1,659,314
shares
|
$29.4 Million
0.02% of portfolio
|
Q3 2024
Reduced 1.67%
|
|
Voloridge Investment Management, LLC
Jupiter, FL |
Nov 14, 2024 Q3 2024 |
1,028,425
shares
|
$18.2 Million
0.06% of portfolio
|
Q3 2024
Reduced 6.9%
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Nov 13, 2024 Q3 2024 |
997,444
shares
|
$17.7 Million
0.04% of portfolio
|
Q3 2024
Added 34.26%
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Nov 14, 2024 Q3 2024 |
963,900
shares
|
$17.1 Million
0.04% of portfolio
|
Q3 2024
Reduced 26.94%
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
923,509
shares
|
$16.4 Million
0.0% of portfolio
|
Q3 2024
Added 84.17%
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Nov 14, 2024 Q3 2024 |
907,999
shares
|
$16.1 Million
0.0% of portfolio
|
Q3 2024
Added 10.28%
|
|
Frontier Capital Management CO LLC
|
Nov 14, 2024 Q3 2024 |
871,420
shares
|
$15.5 Million
0.14% of portfolio
|
Q3 2024
Reduced 15.26%
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
847,520
shares
|
$15 Million
0.01% of portfolio
|
Q1 2024
Reduced 0.7%
|
|
Balyasny Asset Management LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
839,174
shares
|
$14.9 Million
0.02% of portfolio
|
Q3 2024
Added 41.04%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
824,443
shares
|
$14.6 Million
0.0% of portfolio
|
Q3 2024
Added 2.02%
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
785,745
shares
|
$13.9 Million
0.0% of portfolio
|
Q3 2024
Added 225.34%
|
|
Marshall Wace, LLP
London, X0 |
Nov 14, 2024 Q3 2024 |
779,670
shares
|
$13.8 Million
0.02% of portfolio
|
Q3 2024
Added 56.73%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2024 Q3 2024 |
744,154
shares
|
$13.2 Million
0.02% of portfolio
|
Q3 2024
Reduced 2.11%
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
739,954
shares
|
$13.1 Million
0.03% of portfolio
|
Q3 2024
Reduced 40.53%
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
670,121
shares
|
$11.9 Million
0.0% of portfolio
|
Q3 2024
Reduced 16.91%
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Nov 14, 2024 Q3 2024 |
650,314
shares
|
$11.5 Million
0.01% of portfolio
|
Q3 2024
Reduced 7.0%
|